Literature DB >> 10617730

Less aggressive treatment of neonatal jaundice and reports of kernicterus: lessons about practice guidelines.

T B Newman1, M J Maisels.   

Abstract

The publication of guidelines calling for less aggressive treatment of jaundice in newborns has been followed by a reappearance of case reports of kernicterus. These case reports illustrate important issues for writers and consumers of practice guidelines. One issue is the particular salience of identified patients with bad outcomes, and their potentially disproportionate influence on decision-makers. A second issue is whether, when good evidence of treatment benefit is lacking, policymakers should recommend what has traditionally been done, recommend less treatment, or not make recommendations at all. Finally, the cases raise the question of whether treatment guidelines should be more conservative than their authors actually believe is necessary, to take into account the likelihood that they will not be closely followed. We believe that case reports can serve as an important early warning system, but policymakers should be aware of their potentially disproportionate influence. In the long run, patients and clinicians will be best served by guidelines that summarize and acknowledge the limitations of existing evidence, that allow a wide range of treatment options when evidence is weak, and that recommend what the guideline authors actually believe should be done. In the short run a period of readjustment may be required, however, as clinicians become accustomed to guidelines written to be followed, rather than bent.

Entities:  

Mesh:

Year:  2000        PMID: 10617730

Source DB:  PubMed          Journal:  Pediatrics        ISSN: 0031-4005            Impact factor:   7.124


  11 in total

1.  The power of stories over statistics.

Authors:  Thomas B Newman
Journal:  BMJ       Date:  2003-12-20

2.  Why we are still doing so many exchange blood transfusion for neonatal jaundice in Nigeria.

Authors:  Joshua Aderinsola Owa; Tinuade A Ogunlesi; Titus A Ogunlesi
Journal:  World J Pediatr       Date:  2009-01-27       Impact factor: 2.764

3.  Irradiance readings of phototherapy equipment: Nigeria.

Authors:  Joshua Aderinsola Owa; Olusegun Joseph Adebami; Folorunso Francis Fadero; Tina Marye Slusher
Journal:  Indian J Pediatr       Date:  2011-02-22       Impact factor: 1.967

4.  Incidence and causes of severe neonatal hyperbilirubinemia in Canada.

Authors:  Michael Sgro; Douglas Campbell; Vibhuti Shah
Journal:  CMAJ       Date:  2006-09-12       Impact factor: 8.262

5.  Can haptoglobin be an indicator for the early diagnosis of neonatal jaundice?

Authors:  Alpay Cakmak; Mustafa Calik; Ali Atas; Ibrahim Hirfanoglu; Ozcan Erel
Journal:  J Clin Lab Anal       Date:  2008       Impact factor: 2.352

6.  Unbound bilirubin measurements in term and late-preterm infants.

Authors:  Thomas Hegyi; Dalya Chefitz; Alan Weller; Andrew Huber; Mary Carayannopoulos; Alan Kleinfeld
Journal:  J Matern Fetal Neonatal Med       Date:  2020-05-04

7.  Hyperbilirubinemia and neurodevelopmental outcome of very low birthweight infants: results from the LIFT cohort.

Authors:  Gaël Mazeiras; Jean-Christophe Rozé; Pierre-Yves Ancel; Gaëlle Caillaux; Anne Frondas-Chauty; Sophie Denizot; Cyril Flamant
Journal:  PLoS One       Date:  2012-01-27       Impact factor: 3.240

8.  Severe neonatal hyperbilirubinemia leading to exchange transfusion.

Authors:  Peymaneh Alizadeh Taheri; Mandana Sadeghi; Negar Sajjadian
Journal:  Med J Islam Repub Iran       Date:  2014-07-14

9.  Management of neonatal hyperbilirubinemia: pediatricians' practices and educational needs.

Authors:  Anna Petrova; Rajeev Mehta; Gillian Birchwood; Barbara Ostfeld; Thomas Hegyi
Journal:  BMC Pediatr       Date:  2006-03-06       Impact factor: 2.125

10.  Evaluation of risk factors for development of severe hyperbilirubinemia in term and near term infants in Turkey.

Authors:  Ali Bulbul; Nihal Cayonu; Merve Emecen Sanli; Sinan Uslu
Journal:  Pak J Med Sci       Date:  2014-09       Impact factor: 1.088

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.